Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-01-01 @ 11:24 AM
Study NCT ID:
NCT02903004
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2016-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-26
First Submit QC Date:
None
Study First Post Date:
2016-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-24
Last Update Post Date:
2021-08-25
Last Update Post Date Type:
ACTUAL